Results 91 to 100 of about 314,031 (226)
Derivatives of MOPS: promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition
The SARS‐CoV/CoV‐2 genome encodes non‐structural protein 3, which contains a ‘Macro domain’. This protein domain exhibits antagonistic activity against interferon signaling, which disrupts the host innate immune response and can thus mediate viral escape, highlighting its therapeutic potential.
Oney Ortega Granda+5 more
wiley +1 more source
A method for the screening of tetanus and diphtheria antibodies in serum using anatoxin (inactivated toxin) instead of toxin was developed as an alternative to the in vivo toxin neutralization assay based on the toxin-binding inhibition test (TOBI test).
M.H. Sonobe+8 more
doaj
ACTIVE IMMUNITY PRODUCED BY SO CALLED BALANCED OR NEUTRAL MIXTURES OF DIPHTHERIA TOXIN AND ANTITOXIN
The foregoing and earlier data taken together demonstrate that an active immunity lasting several years can be produced in guinea-pigs, by the injection of toxin-antitoxin mixtures which have no recognizable harmful effect either immediate or remote ...
Theobald. Smith
semanticscholar +1 more source
Functional verification of the diphtheria toxin A gene in a recombinant system
Diphtheria toxin A (DTA), a segment of the diphtheria toxin (tox), inhibits protein synthesis in cells. When released from a cell, DTA is nontoxic and cannot enter other cells independently without the help of diphtheria toxin B.
Zhang Jingfeng+6 more
doaj +1 more source
Notes on the Production of Immunity to Diphtheria Toxin
(a) Primary Stimulus. In animals possessing no normal antitoxin a single injection of toxin either “attenuated” or under cover of antitoxin, whether injected previously or at the same time or present in the form of passive immunity maternally transmitted,
A. Glenny, H. J. Südmersen
semanticscholar +1 more source
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
ABSTRACT Disease Overview Acute myeloid leukemia (AML) is a bone marrow stem cell cancer that is often fatal despite available treatments. Diagnosis, risk assessment, monitoring, and therapeutic management of AML have changed dramatically in the last decade due to increased pathophysiologic understanding, improved assessment technology, and the ...
Shai Shimony+2 more
wiley +1 more source
Toxin-allelopathy among phytoplankton species prevents competitive exclusion [PDF]
Toxic or allelopathic compounds liberated by toxin-producing phytoplankton (TPP) acts as a strong mediator in plankton dynamics. On an analysis of a set of phytoplankton biomass-data that have been collected by our group in the North-West part of the Bay of Bengal, and by analysis of a three-component mathematical model under a constant as well as a ...
arxiv
CD11c‐Expressing Microglia Are Transient, Driven by Interactions With Apoptotic Cells
Main Points Recognition of apoptotic cells drives transient microglial CD11c expression. CD11c microglia are highly phagocytic and have elevated lysosomal content. CD11c state is partly dependent on Axl and they transition out as apoptotic cells are cleared.
Nathaniel Ghena+6 more
wiley +1 more source
NECESSITY OF TRANSLOCATION DOMAIN FOR REALISATION OF CYTOSTATIC EFFECT OF NON-TOXIC DERIVATIVES OF DIPHTHERIA TOXIN [PDF]
The aim of the work was to evaluate in vitro the cytostatic effect of recombinant fragments of the non-toxic point mutant of diphtheria toxin — CRM197, which was suggested as a potent medication for treatment of triple negative breast cancer.
K. Y. Manoilov+4 more
doaj +1 more source
USP13 is a promising therapeutic target for cellular proliferation in multiple myeloma. Bruceine A can retard the development of multiple myeloma by targeting USP13/PARP1‐mediated DNA damage repair and triggering cell apoptosis. ABSTRACT Multiple myeloma (MM) is an incurable hematologic malignancy, driving significant interest in the discovery of novel
Mengjie Guo+9 more
wiley +1 more source